Bare Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.14K Buy
10
+3
+43% +$341 ﹤0.01% 881
2025
Q1
$736 Buy
+7
New +$736 ﹤0.01% 630